AFG
UTHR icon

Atomi Financial Group’s United Therapeutics UTHR Stock Holding History

Atomi Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Sell
519
-102
-16% -$50.8K 0.01% 933
2025
Q4 		$303K Buy
621
+75
+14% +$34.9K 0.01% 929
2025
Q3 		$229K Buy
+546
New +$184K 0.01% 1042

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Atomi Financial Group's UTHR Position: Q1 2026 in Review

Atomi Financial Group reduced its United Therapeutics (UTHR) stake by 16% in Q1 2026, selling an estimated $50.8K and leaving 519 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #933.

Atomi Financial Group first reported a position in UTHR in Q3 2025 and has held it in 3 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Atomi Financial Group held 519 shares of United Therapeutics worth $308K as of Q1 2026.
  • Atomi Financial Group sold 102 United Therapeutics shares in Q1 2026, an estimated $50.8K.
  • United Therapeutics made up 0.01% of Atomi Financial Group's portfolio in Q1 2026, its #933 holding.
  • Atomi Financial Group first reported a position in United Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.